Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Equity Ratio (2016 - 2025)

Acro Biomedical has reported Equity Ratio over the past 10 years, most recently at 27.45 for Q4 2025.

  • Quarterly results put Equity Ratio at 27.45 for Q4 2025, down 197.53% from a year ago — trailing twelve months through Dec 2025 was 27.45 (down 197.53% YoY), and the annual figure for FY2025 was 27.45, down 197.53%.
  • Equity Ratio for Q4 2025 was 27.45 at Acro Biomedical, up from 100.07 in the prior quarter.
  • Over the last five years, Equity Ratio for ACBM hit a ceiling of 0.91 in Q2 2021 and a floor of 100.07 in Q3 2025.
  • Median Equity Ratio over the past 5 years was 1.89 (2023), compared with a mean of 9.14.
  • Biggest five-year swings in Equity Ratio: plummeted 1746.94% in 2023 and later surged 41.38% in 2024.
  • Acro Biomedical's Equity Ratio stood at 0.85 in 2021, then fell by 16.35% to 0.71 in 2022, then tumbled by 721.44% to 4.4 in 2023, then tumbled by 109.84% to 9.23 in 2024, then tumbled by 197.53% to 27.45 in 2025.
  • The last three reported values for Equity Ratio were 27.45 (Q4 2025), 100.07 (Q3 2025), and 5.96 (Q2 2025) per Business Quant data.